DR-18
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DR-18, covering 2026-02-09 to 2026-02-09. Get the full timeline:
Most recent: Clinical Trial Update: DR-18 for the Treatment of Relapsed or Persistent Acute Myeloid Leukemia or Myelodysplastic Syndrome After Hematopoietic Cell Transplantation, the DR. DREAM Trial [Phase 1]